Föller Michael, Bobbala Diwakar, Koka Saisudha, Huber Stephan M, Gulbins Erich, Lang Florian
Department of Physiology, University of Tübingen, Tübingen, Germany.
Cell Physiol Biochem. 2009;24(3-4):133-40. doi: 10.1159/000233238. Epub 2009 Aug 3.
The pathogen of malaria, Plasmodium, enters erythrocytes and thus escapes recognition by the immune system. The pathogen induces oxidative stress to the host erythrocyte, which triggers eryptosis, the suicidal death of erythrocytes. Eryptosis is characterized by cell shrinkage, membrane blebbing and cell membrane phospholipid scrambling with phosphatidylserine exposure at the cell surface. Phosphatidylserine-exposing erythrocytes are identified by macrophages which engulf and degrade the eryptotic cells. To the extent that infected erythrocytes undergo eryptosis prior to exit of Plasmodiaand subsequent infection of other erythrocytes, the premature eryptosis may protect against malaria. Accordingly, any therapeutical intervention accelerating suicidal death of infected erythrocytes has the potential to foster elimination of infected erythrocytes, delay the development of parasitemia and favorably influence the course of malaria. Eryptosis is stimulated by a wide variety of triggers including osmotic shock, oxidative stress, energy depletion and a wide variety of xenobiotics. Diseases associated with accelerated eryptosis include sepsis, haemolytic uremic syndrome, malaria, sickle-cell anemia, beta-thalassemia, glucose-6-phosphate dehydrogenase (G6PD)-deficiency, phosphate depletion, iron deficiency and Wilson's disease. Among the known stimulators of eryptosis, paclitaxel, chlorpromazine, cyclosporine, curcumin, PGE2 and lead have indeed been shown to favourably influence the course of malaria. Moreover, sickle-cell trait, beta-thalassemia trait, glucose-6-phosphate dehydrogenase (G6PD)-deficiency and iron deficiency confer some protection against a severe course of malaria. Importantly, counteracting Plasmodia by inducing eryptosis is not expected to generate resistance of the pathogen, as the proteins involved in suicidal death of the host cell are not encoded by the pathogen and thus cannot be modified by mutations of its genes.
疟疾的病原体疟原虫进入红细胞,从而逃避免疫系统的识别。该病原体对宿主红细胞诱导氧化应激,进而引发红细胞凋亡,即红细胞的自杀性死亡。红细胞凋亡的特征为细胞皱缩、膜泡形成以及细胞膜磷脂紊乱,导致磷脂酰丝氨酸暴露于细胞表面。暴露磷脂酰丝氨酸的红细胞会被巨噬细胞识别,巨噬细胞会吞噬并降解这些凋亡细胞。在疟原虫离开之前以及随后感染其他红细胞之前,受感染的红细胞若发生凋亡,那么这种过早的凋亡可能会预防疟疾。因此,任何加速受感染红细胞自杀性死亡的治疗干预措施都有可能促进受感染红细胞的清除,延缓寄生虫血症的发展,并对疟疾病程产生有利影响。多种触发因素均可刺激红细胞凋亡,包括渗透压休克、氧化应激、能量耗竭以及多种外源性物质。与红细胞凋亡加速相关的疾病包括败血症、溶血性尿毒症综合征、疟疾、镰状细胞贫血、β地中海贫血、葡萄糖-6-磷酸脱氢酶(G6PD)缺乏症、磷酸盐缺乏、缺铁以及威尔逊氏病。在已知的红细胞凋亡刺激物中,紫杉醇、氯丙嗪、环孢素、姜黄素、前列腺素E2和铅确实已被证明对疟疾病程有有利影响。此外,镰状细胞性状、β地中海贫血性状、葡萄糖-6-磷酸脱氢酶(G6PD)缺乏症和缺铁对严重疟疾病程有一定的保护作用。重要的是,通过诱导红细胞凋亡来对抗疟原虫预计不会产生病原体耐药性,因为参与宿主细胞自杀性死亡的蛋白质并非由病原体编码,因此不会因病原体基因突变而发生改变。